Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0036 | 1 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |
mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |